Mark Crowther

68.0k citations
592 papers · 42.3k · 19 hit papers · h-index 97

Impact in

    • Venous Thromboembolism Diagnosis and Management
  • Hematology top 0.02%
    • Blood Coagulation and Thrombosis Mechanisms
    • Platelet Disorders and Treatments

Papers in

Mark Crowther

570 papers receiving 40.4k citations

Mark Crowther's Hit Papers

Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum 2019 · 223 citations
2230+5+10Years since publication10002.0k3.0k4.0k

Peers

Mark Crowther
Comparison fields: 5 of 199
  • Internal Medicine 17.6k
  • Hematology 8.0k
  • Cardiology and Cardiovascular Medicine 15.0k
  • Critical Care and Intensive Care Medicine 1.7k
  • Emergency Medical Services 1.9k
Replace Jack Hirsh with:
Jack Hirsh Canada
Harry R. Büller Netherlands
Frits R. Rosendaal Netherlands
Sam Schulman Canada
Samuel Z. Goldhaber United States
Martin H. Prins Netherlands
John A. Heit United States
Clive Kearon Canada
Mark N. Levine Canada
David R. Anderson Canada
Mark Crowther relative to Jack Hirsh Canada Jack Hirsh's profile →
Citations per field
00.5×3.3×
Jack Hirsh · 1×
Citations per year

Countries citing papers authored by Mark Crowther

Since Specialization
Citations

This map shows the geographic impact of Mark Crowther's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Crowther with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Crowther more than expected).

Fields of papers citing papers by Mark Crowther

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Crowther. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Crowther. The network helps show where Mark Crowther may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Crowther, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Crowther Line = papers co-authored together Mark Crowther links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 592 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Antithrombotic Therapy for VTE Disease
Hit paper breakdown →
20124709
2
Pharmacology and Management of the Vitamin K Antagonists
Hit paper breakdown →
20081690
3
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
Hit paper breakdown →
20111355
4
Executive Summary
Hit paper breakdown →
20121163
5
Oral Anticoagulant Therapy
Hit paper breakdown →
20121163
6
Evidence-Based Management of Anticoagulant Therapy
Hit paper breakdown →
2012942
7
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
Hit paper breakdown →
2015757
8
Treatment and Prevention of Heparin-Induced Thrombocytopenia
Hit paper breakdown →
2012729
9
A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome
Hit paper breakdown →
2003680
10
Antiphospholipid syndrome
Hit paper breakdown →
2010575
11
Comparison of Low-Intensity Warfarin Therapy with Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism
Hit paper breakdown →
2003573
12
Acute Kidney Injury After Cardiac Surgery
Hit paper breakdown →
2009544
13
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection
Hit paper breakdown →
2016503
14
Diagnosis of DVT
Hit paper breakdown →
2012484
15 2007428
16 2008422
17 2007389
18
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: Report of a Task Force at the 13th International Congress on Antiphospholipid Antibodies
Hit paper breakdown →
2011363
19
American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy
Hit paper breakdown →
2018359
20
Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis
Hit paper breakdown →
2012342

About Mark Crowther

Mark Crowther is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Hematology, Surgery and Rheumatology, having authored 592 papers that have together received 42.3k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (251 papers), Atrial Fibrillation Management and Outcomes (166 papers), Heparin-Induced Thrombocytopenia and Thrombosis (62 papers), Platelet Disorders and Treatments (51 papers), Blood Coagulation and Thrombosis Mechanisms (38 papers), Systemic Lupus Erythematosus Research (35 papers), Antiplatelet Therapy and Cardiovascular Diseases (26 papers) and Acute Myocardial Infarction Research (25 papers). The work is most often cited by research in Internal Medicine (17.6k citations), Hematology (8.0k citations), Cardiology and Cardiovascular Medicine (15.0k citations), Critical Care and Intensive Care Medicine (1.7k citations) and Emergency Medical Services (1.9k citations). Mark Crowther has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include Wendy Lim, Elie A. Akl, Elaine M. Hylek, Walter Ageno, Francesco Dentali, Clive Kearon, Gordon Guyatt, Susan R. Kahn, Philip S. Wells and David García. Their work appears in journals such as Blood, Journal of Thrombosis and Haemostasis, Thrombosis Research, Thrombosis and Haemostasis and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact